Abstract
Oxidized phospholipids (OxPL) appear in the lung circulation as a result of increased oxidative stress that accompanies pathological conditions such as acute lung injury, lung inflammation, adult respiratory distress syndrome (ARDS), ventilator-induced lung injury (VILI), systemic inflammatory response syndrome (SIRS) and sepsis. Under these conditions, lung vascular barrier function is largely compromised. The severity of vascular endothelial dysfunction is determined by a balance between barrier-disruptive and barrier-protective agents present in the pulmonary circulation. Oxidation of phospholipids such as 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) generates a group of bioactive oxidized phospholipid species that demonstrate a wide spectrum of physiological effects including activation of monocyte adhesion to endothelial cells and attenuation of inflammatory cascades triggered by bacterial lipopolysaccharide (LPS). Moreover, our studies and other previous reports strongly suggest barrier-protective effects of OxPAPC on human pulmonary EC, and EC from systemic circulation. In this review, we will discuss a potential role for biologically active oxidized phospholipids in the regulation of vascular barrier integrity and LPS-induced inflammation in the injured lung.
Keywords: Oxidized phospholipids, lung injury, inflammation, endothelial permeability, signal transduction, cytoskeleton
Current Respiratory Medicine Reviews
Title: Role of Oxidized Phospholipids in Acute Lung Injury
Volume: 2 Issue: 1
Author(s): Valery N. Bochkov, Norbert Leitinger and Konstantin G. Birukov
Affiliation:
Keywords: Oxidized phospholipids, lung injury, inflammation, endothelial permeability, signal transduction, cytoskeleton
Abstract: Oxidized phospholipids (OxPL) appear in the lung circulation as a result of increased oxidative stress that accompanies pathological conditions such as acute lung injury, lung inflammation, adult respiratory distress syndrome (ARDS), ventilator-induced lung injury (VILI), systemic inflammatory response syndrome (SIRS) and sepsis. Under these conditions, lung vascular barrier function is largely compromised. The severity of vascular endothelial dysfunction is determined by a balance between barrier-disruptive and barrier-protective agents present in the pulmonary circulation. Oxidation of phospholipids such as 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) generates a group of bioactive oxidized phospholipid species that demonstrate a wide spectrum of physiological effects including activation of monocyte adhesion to endothelial cells and attenuation of inflammatory cascades triggered by bacterial lipopolysaccharide (LPS). Moreover, our studies and other previous reports strongly suggest barrier-protective effects of OxPAPC on human pulmonary EC, and EC from systemic circulation. In this review, we will discuss a potential role for biologically active oxidized phospholipids in the regulation of vascular barrier integrity and LPS-induced inflammation in the injured lung.
Export Options
About this article
Cite this article as:
Bochkov N. Valery, Leitinger Norbert and Birukov G. Konstantin, Role of Oxidized Phospholipids in Acute Lung Injury, Current Respiratory Medicine Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339806775486182
DOI https://dx.doi.org/10.2174/157339806775486182 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals
Current Gene Therapy Gene Therapy for Wiskott-Aldrich Syndrome
Current Gene Therapy The Use of Radioactive Iodine in the Management of Hyperthyroidism in Children
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Current Pharmaceutical Design Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Mixed Connective Tissue Disease (MCTD) – A Coming of Age
Current Rheumatology Reviews Radiofluorinated Carbohydrates for Positron Emission Tomography
Current Topics in Medicinal Chemistry Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
Current Drug Targets Role of Positron Emission Tomography for Central Nervous System Involvement in Systemic Autoimmune Diseases: Status and Perspectives
Current Medicinal Chemistry Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
Current Vascular Pharmacology 4’-Aminochalcones As Novel Inhibitors of the Chlorinating Activity of Myeloperoxidase
Current Medicinal Chemistry Application of Resveratrol in Diabetes: Rationale, Strategies and Challenges
Current Molecular Medicine Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
Current Alzheimer Research Immunoglobulin Therapy, Myocardial Diseases and Atherosclerosis:Recent Experimental and Clinical Studies
Current Cardiology Reviews Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
Current Medicinal Chemistry Cardiac and Muscular Involvement in Idiopathic Inflammatory Myopathies: Noninvasive Diagnostic Assessment and the Role of Cardiovascular and Skeletal Magnetic Resonance Imaging
Inflammation & Allergy - Drug Targets (Discontinued) Regulation of Platelet Function by Acetylation/Deacetylation Mechanisms
Current Medicinal Chemistry Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Advances in Delivery of Biotherapeutics Across the Blood-Brain Barrier
Current Drug Discovery Technologies Development of Infection and Inflammation Targeting Compounds
Current Radiopharmaceuticals